COMPASS Pathways plc (CMPS)Healthcare | Medical Care Facilities | London, United Kingdom | NasdaqGS
13.13 USD
-0.06
(-0.418%) ⇩
(July 14, 2026, 9:51 a.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:52 a.m. EDT
The investment case here is defined by a stark contradiction between a catastrophic long-term trajectory and aggressive short-term speculation. Fundamentally, the business is in freefall; the stock has lost over 90% of its value over the last four years, with every single year showing negative returns. The company is burning cash, posting negative returns on equity and assets, and trading at a negative earnings multiple. There is no dividend to cushion the blow, and the balance sheet shows deteriorating fundamentals rather than a fortress. While the price has recently stabilized near the 52-week low, the multi-year trend is unequivocally downward. However, the short-term outlook is being fueled entirely by options flow and sector hype. Traders are pouring capital into calls at strikes significantly higher than the current price, betting on a 'regulatory shot' or a pipeline milestone that could reverse the trend. This creates a volatile, high-beta environment where the stock acts less like a traditional medical device company and more like a speculative biotech lottery ticket. For a value investor, the math is broken; for a momentum trader, the options chain suggests a crowded trade waiting for a catalyst to pop the price. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.296261 |
| AutoTheta | 0.304414 |
| AutoETS | 0.308778 |
| AutoARIMA | 0.308783 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 31% |
| H-stat | 8.35 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.507 |
| Excess Kurtosis | -0.75 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 16.318 |
| Market Cap | 1,771,870,976 |
| Forward P/E | -12.10 |
| Beta | 2.49 |
| Website | https://compasspathways.com |
As of July 11, 2026, 3:52 a.m. EDT: Speculators are positioning aggressively for a rebound, evidenced by massive call volume and open interest at strikes above the current price (16.0 and 20.0), while put activity remains thin and concentrated at lower strikes. Implied volatility is elevated, suggesting a belief in significant upside movement driven by potential regulatory milestones, despite the lack of recent price confirmation.
| Attribute | Value |
|---|---|
| 52 Week Change | 2.7036517 |
| Address1 | 33 Broadwick Street |
| All Time High | 61.69 |
| All Time Low | 2.25 |
| Ask | 16.72 |
| Ask Size | 2 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 5,112,240 |
| Average Daily Volume3 Month | 4,887,690 |
| Average Volume | 4,887,690 |
| Average Volume10Days | 5,112,240 |
| Beta | 2.487 |
| Bid | 9.61 |
| Bid Size | 2 |
| Book Value | 2.421 |
| City | London |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 13.1299 |
| Current Ratio | 3.322 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 13.37 |
| Day Low | 12.9408 |
| Debt To Equity | 16.318 |
| Display Name | COMPASS Pathways |
| Earnings Call Timestamp End | 1,778,673,600 |
| Earnings Call Timestamp Start | 1,778,673,600 |
| Earnings Timestamp | 1,778,675,400 |
| Earnings Timestamp End | 1,785,414,600 |
| Earnings Timestamp Start | 1,785,414,600 |
| Ebitda | -174,316,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -7.84 |
| Enterprise Value | 1,366,605,824 |
| Eps Current Year | -0.995 |
| Eps Forward | -1.085 |
| Eps Trailing Twelve Months | -3.04 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 11.8827 |
| Fifty Day Average Change | 1.2472 |
| Fifty Day Average Change Percent | 0.10495931 |
| Fifty Two Week Change Percent | 270.36517 |
| Fifty Two Week High | 15.4 |
| Fifty Two Week High Change | -2.2700996 |
| Fifty Two Week High Change Percent | -0.14740907 |
| Fifty Two Week Low | 3.5 |
| Fifty Two Week Low Change | 9.6299 |
| Fifty Two Week Low Change Percent | 2.7514 |
| Fifty Two Week Range | 3.5 - 15.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,600,435,800,000 |
| Float Shares | 101,485,937 |
| Forward Eps | -1.085 |
| Forward P E | -12.10129 |
| Free Cashflow | 33,066,624 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 156 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07828 |
| Held Percent Institutions | 0.72317004 |
| Implied Shares Outstanding | 134,949,320 |
| Industry | Medical Care Facilities |
| Industry Disp | Medical Care Facilities |
| Industry Key | medical-care-facilities |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. |
| Long Name | COMPASS Pathways plc |
| Market | us_market |
| Market Cap | 1,771,870,976 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_576453668 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -192,363,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,779,306,784 |
| Number Of Analyst Opinions | 15 |
| Open | 13.2 |
| Operating Cashflow | -159,519,008 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 44 716 6766461 |
| Previous Close | 13.185 |
| Price Eps Current Year | -13.195879 |
| Price Hint | 2 |
| Price To Book | 5.4233375 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.128 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | -0.05510044 |
| Regular Market Change Percent | -0.41790247 |
| Regular Market Day High | 13.37 |
| Regular Market Day Low | 12.9408 |
| Regular Market Day Range | 12.9408 - 13.37 |
| Regular Market Open | 13.2 |
| Regular Market Previous Close | 13.185 |
| Regular Market Price | 13.1299 |
| Regular Market Time | 1,784,037,107 |
| Regular Market Volume | 247,821 |
| Return On Assets | -0.25643 |
| Return On Equity | -0.68484 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 134,949,320 |
| Shares Percent Shares Out | 0.0754 |
| Shares Short | 10,173,681 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 7,329,982 |
| Short Name | COMPASS Pathways Plc - American |
| Short Percent Of Float | 0.0764 |
| Short Ratio | 2.82 |
| Source Interval | 15 |
| Symbol | CMPS |
| Target High Price | 70.0 |
| Target Low Price | 17.0 |
| Target Mean Price | 24.46667 |
| Target Median Price | 21.0 |
| Total Cash | 466,009,984 |
| Total Cash Per Share | 3.453 |
| Total Debt | 53,309,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.8275 |
| Two Hundred Day Average Change | 5.3024 |
| Two Hundred Day Average Change Percent | 0.6774066 |
| Type Disp | Equity |
| Volume | 247,821 |
| Website | https://compasspathways.com |
| Zip | W1F 0DQ |